McKesson Corporation (NYSE:MCK) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. McKesson (MCK) Gets Higher Target at Deutsche Bank Despite Planned Spin-Off On December 10, Deutsche Bank analyst George Hill raised the firm’s price target on McKesson Corporation (NYSE:MCK) to $904 from $861 and kept a Buy rating on the shares. In a research note, the analyst said the company reiterated plans to exit its med-surgical business through an initial public offering, followed by a spin-off or ...